![Rank: 8](static/image/common/star_level3.gif) ![Rank: 8](static/image/common/star_level3.gif)
- 现金
- 62111 元
- 精华
- 26
- 帖子
- 30437
- 注册时间
- 2009-10-5
- 最后登录
- 2022-12-28
|
| The Liver Meeting
San Francisco
November 2018 | Back ![](http://natap.org/images/misc/grey_arrow_rt.gif) |
|
| | ![](http://natap.org/2018/AASLD/images/null.gif) | ![](http://natap.org/2018/AASLD/images/null.gif) | ![](http://natap.org/2018/AASLD/images/null.gif) |
| PREDICTABILITY OF SERUM HBcrAg, HBsAg AND INTERFERON INDUCIBLE PROTEIN 10 (IP10) LEVELS IN NON-CIRRHOTIC HBeAg-NEGATIVE CHRONIC HEPATITIS B PATIENTS WHO DISCONTINUE ENTECAVIR (ETV) OR TENOFOVIR (TDF) THERAPY: RESULTS FROM THE PROSPECTIVE DARING-B STUDY
|
|
| Reported by Jules Levin
AASLD 2018 Nov 9-13 SF
M Papatheodoridi1, E Hadziyannis2, F Berby3, E Rigopoulou4, K Zachou4, B Testoni3, A Lyberopoulou4, N Gatselis4, J Vlachogiannakos1, S Manolakopoulos1,2, GN Dalekos4, F Zoulim3, GV Papatheodoridis1.
1Department of Gastroenterology, Medical School of National and Kapodistrian University of Athens, Laiko General Hospital, Athens, Greece; 2Department of Medicine and Research Laboratory of Internal Medicine, Thessaly University Medical School, Larissa, Greece; 3Department of Hepatology, Hospices Civils de Lyon, CRCL-INSERM U1052, Lyon University, Lyon, France;42nd Department of Internal Medicine, Medical School of National and Kapodistrian University of Athens, Hippokratio General Hospital, Athens, Greece.![](http://natap.org/2018/images%20/010218/010219-2/0102191.gif)
![](http://natap.org/2018/images%20/010218/010219-2/0102192.gif)
![](http://natap.org/2018/images%20/010218/010219-2/0102193.gif)
![](http://natap.org/2018/images%20/010218/010219-2/0102194.gif)
![](http://natap.org/2018/images%20/010218/010219-2/0102195.gif)
![](http://natap.org/2018/images%20/010218/010219-2/0102196.gif)
|
|
|
|
|
|